Add like
Add dislike
Add to saved papers

Prognostic Impact of Recurrences in Patients with Electrical Storm.

OBJECTIVES: The study sought to assess the prognostic impact of recurrences of electrical storm (ES-R) on mortality, rehospitalization and major adverse cardiac events (MACE).

BACKGROUND: Data on the prognostic impact of ES-R is rare.

METHODS: All consecutive ES patients with implantable cardioverter defibrillator (ICD) were included retrospectively from 2002 to 2016. Patients with ES-R were compared to patients without ES-R. The primary prognostic endpoint was all-cause mortality, secondary endpoints were in-hospital mortality, rehospitalization rates and MACE.

RESULTS: A total of 87 ES patients with ICD were included, of which 26% presented ES-R at 2.5 years of follow-up. ES-R patients revealed lower LVEF compared to no ES-R patients (91% vs. 61%; p = 0.081). There was a higher rate of the primary prognostic endpoint all-cause mortality at 2.5 years (50% vs. 32%; log-rank p = 0.137). Furthermore, ES-R was associated with increasing rates of rehospitalization (64% vs. 37%; p = 0.031; HR 1.985; 95% CI 1.025-3.845; log-rank p = 0.042), especially of acute heart failure (32% vs. 12%; p = 0.001; HR 3.262; 95% CI 1.180-9.023; log rank p = 0.023). MACE were higher in ES-R patients (55% vs. 35%; p = 0.113; log rank p = 0.141). ES patients with LVEF ≤35% were 12.4 times more likely to develop ES-R (HR 12.417; 95% CI 1.329-115.997; p = 0.027).

CONCLUSION: At long-term follow-up of 2.5 years, ES-R was associated with numerically higher long-term all-cause mortality and with significantly increasing rates of re-hospitalization due to acute heart failure. LVEF ≤35% was associated with increased risk of ES-R.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app